Literature DB >> 1941963

A closely linked DNA marker for facioscapulohumeral disease on chromosome 4q.

M Upadhyaya1, P W Lunt, M Sarfarazi, W Broadhead, J Daniels, M Owen, P S Harper.   

Abstract

Close linkage of a hypervariable DNA probe on chromosome 4q (pH30, locus D4S139) has been found with the locus for facioscapulohumeral disease. Three recombinants were identified in a total of 140 meioses, giving a maximum lod score of 36.77 at a recombination fraction of 0.02. All but two of the families studied proved informative with this probe; all informative families showed evidence of linkage (except one family with a single scorable meiosis), making genetic heterogeneity unlikely from our data. The close linkage and highly informative nature of the probe will make it suitable for clinical application in presymptomatic and prenatal diagnosis. We have also confirmed loose linkage with the marker (Mfd22, locus D4S171) used to establish the initial assignment of the disorder to chromosome 4.

Mesh:

Substances:

Year:  1991        PMID: 1941963      PMCID: PMC1017052          DOI: 10.1136/jmg.28.10.665

Source DB:  PubMed          Journal:  J Med Genet        ISSN: 0022-2593            Impact factor:   6.318


  24 in total

1.  A pedigree of hereditary progressive muscular dystrophy.

Authors:  J W BOYES; F C FRASER
Journal:  Ann Eugen       Date:  1949-10

2.  Factor XI gene (F11) is located on the distal end of the long arm of human chromosome 4.

Authors:  A Kato; R Asakai; E W Davie; N Aoki
Journal:  Cytogenet Cell Genet       Date:  1989

3.  An exclusion map for facioscapulohumeral (Landouzy-Déjérine) disease.

Authors:  M Sarfarazi; M Upadhyaya; G Padberg; M Pericak-Vance; T Siddique; G Lucotte; P Lunt
Journal:  J Med Genet       Date:  1989-08       Impact factor: 6.318

4.  Hearing loss in facioscapulohumeral dystrophy.

Authors:  T Voit; A Lamprecht; H G Lenard; H H Goebel
Journal:  Eur J Pediatr       Date:  1986-09       Impact factor: 3.183

5.  Evidence against location of the gene for facioscapulohumeral muscular dystrophy on the distal long arm of chromosome 14.

Authors:  P W Lunt; J G Noades; M Upadhyaya; M Sarfarazi; P S Harper
Journal:  J Neurol Sci       Date:  1988-12       Impact factor: 3.181

6.  A technique for radiolabeling DNA restriction endonuclease fragments to high specific activity.

Authors:  A P Feinberg; B Vogelstein
Journal:  Anal Biochem       Date:  1983-07-01       Impact factor: 3.365

7.  Linkage studies in autosomal dominant facioscapulohumeral muscular dystrophy.

Authors:  G Padberg; A W Eriksson; W S Volkers; L Bernini; E Van Loghem; P Meera Khan; L E Nijenhuis; J C Pronk; G M Schreuder
Journal:  J Neurol Sci       Date:  1984-09       Impact factor: 3.181

8.  Genetic counselling in facioscapulohumeral muscular dystrophy.

Authors:  P W Lunt; P S Harper
Journal:  J Med Genet       Date:  1991-10       Impact factor: 6.318

9.  Retinal vascular abnormalities in facioscapulohumeral muscular dystrophy. A general association with genetic and therapeutic implications.

Authors:  R B Fitzsimons; E B Gurwin; A C Bird
Journal:  Brain       Date:  1987-06       Impact factor: 13.501

10.  Location of facioscapulohumeral muscular dystrophy gene on chromosome 4.

Authors:  C Wijmenga; R R Frants; O F Brouwer; P Moerer; J L Weber; G W Padberg
Journal:  Lancet       Date:  1990-09-15       Impact factor: 79.321

View more
  4 in total

Review 1.  The DNA laboratory and neurological practice.

Authors:  A E Harding
Journal:  J Neurol Neurosurg Psychiatry       Date:  1993-03       Impact factor: 10.154

2.  Evidence for heterogeneity in facioscapulohumeral muscular dystrophy (FSHD).

Authors:  J R Gilbert; J M Stajich; S Wall; S C Carter; H Qiu; J M Vance; C S Stewart; M C Speer; J Pufky; L H Yamaoka
Journal:  Am J Hum Genet       Date:  1993-08       Impact factor: 11.025

3.  Genetic counselling in facioscapulohumeral muscular dystrophy.

Authors:  P W Lunt; P S Harper
Journal:  J Med Genet       Date:  1991-10       Impact factor: 6.318

4.  Facioscapulohumeral Muscular Dystrophy: More Complex than it Appears.

Authors:  G Ricci; M Zatz; R Tupler
Journal:  Curr Mol Med       Date:  2014       Impact factor: 2.222

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.